Fox Chase Cancer Center to Host FREE Program on Lynch Syndrome
PHILADELPHIA, PA (March 11, 2013)—Fox Chase Cancer Center invites patients and their friends and families to attend a Lynch Syndrome Public Awareness Event on Thursday, March 21, at Fox Chase’s Campus (333 Cottman Avenue, Philadelphia). The evening will begin with appetizers at 6:30 p.m. on the 2nd floor mezzanine of the Young Pavilion followed by the program at 7:00 p.m.
Lynch syndrome is an inherited condition that increases a person’s risk of colon cancer as well as other types of cancers. During the program, Michael J. Hall, MD, director of gastrointestinal risk assessment at Fox Chase, will speak about patient care options, and Lynch syndrome patient advocate and previvor, Laura Simonetti, will share her personal story.
This event is hosted by the gastrointestinal section of the Fox Chase’s Risk Assessment Program. To register, please contact Theresa Guglielmi at 215-728-7041.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.